Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-14
DOI
10.1038/s41409-019-0636-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series
- (2018) Robin Vos et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Lung transplantation after allogeneic stem cell transplantation: a pan-European experience
- (2018) Mark Greer et al. EUROPEAN RESPIRATORY JOURNAL
- Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation
- (2018) Anne Bergeron et al. EUROPEAN RESPIRATORY JOURNAL
- Lung histopathology of noninfectious pulmonary complications after allogeneic hematopoietic stem cell transplantation
- (2018) Véronique Meignin et al. HISTOPATHOLOGY
- Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study
- (2017) Yasunori Enomoto et al. RESPIRATORY MEDICINE
- Clinical and radiological characteristics of patients with late-onset severe restrictive lung defect after hematopoietic stem cell transplantation
- (2017) Ho Namkoong et al. BMC Pulmonary Medicine
- Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients
- (2016) Francesca Mariani et al. Diagnostic and Interventional Radiology
- A Patient with Idiopathic Pleuroparenchymal Fibroelastosis Showing a Sustained Pulmonary Function due to Treatment with Pirfenidone
- (2016) Seidai Sato et al. INTERNAL MEDICINE
- Air-leak Syndrome by Pleuroparenchymal Fibroelastosis after Bone Marrow Transplantation
- (2016) Tomoya Ishii et al. INTERNAL MEDICINE
- Pleuroparenchymal fibroelastosis after allogenic hematopoietic stem cell transplantation: important histological component of late-onset noninfectious pulmonary complication accompanied with recurrent pneumothorax
- (2016) Takahiro Matsui et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients
- (2016) Francesca Mariani et al. Diagnostic and Interventional Radiology
- Restrictive chronic lung function decline after haematopoietic stem cell transplantation
- (2015) Ji-Young Yang et al. EUROPEAN RESPIRATORY JOURNAL
- Pleuroparenchymal fibroelastosis and non-specific interstitial pneumonia: frequent pulmonary sequelae of haematopoietic stem cell transplantation
- (2014) Yasuhide Takeuchi et al. HISTOPATHOLOGY
- Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation
- (2014) Frédéric Schlemmer et al. RESPIRATORY MEDICINE
- An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
- (2013) William D. Travis et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pirfenidone: A Potential New Therapy for Restrictive Allograft Syndrome?
- (2013) R. Vos et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes
- (2012) Taryn L. Reddy et al. EUROPEAN RESPIRATORY JOURNAL
- Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis
- (2012) Efrat Ofek et al. MODERN PATHOLOGY
- Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation
- (2011) Jan H von der Thüsen et al. MODERN PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started